Journal of Ophthalmology / 2017 / Article / Tab 2

Review Article

Clinical Features and Treatments of Syphilitic Uveitis: A Systematic Review and Meta-Analysis

Table 2

Clinical characteristics of patients with syphilitic uveitis.

StudyBilaterality (%)AU (%)IU (%)PU (%)PAU (%)ASPPC (%)Retinitis, retinal
vasculitis, neuroretinitis
Papillitis,
optic neuritis
HIV-positive (%)CSF VDRL
positive (%)

Bollemeijier (2016)63.515.81.430.247.586.074.035.938.7
Dai (2016)20.022.014.60.036.0
Fonollosa (2016)86.014.00.052.034.08.623.733.334.015.0
Sahin (2016)41.729.411.829.411.85.90.0
Tsuboi (2016)50.010.06.750.020.06.753.3100.0
Zhang (2016)73.33.017.09.013.3
Lee (2015)81.313.827.644.813.862.520.0
Moradi (2015)74.336.123.08.245.93.354.347.1
Northey (2015)52.032.467.62.72.727.027.032.042.9
Shen (2015)61.54.89.552.414.37.7
Mathew (2014)56.09.51.612.741.322.231.7
Rodrigues (2014)58.35.321.157.95.310.566.722.2
Yap (2014)50.033.35.627.833.344.433.325.044.4
Restivo (2013)50.09.528.650.042.942.9
Eandi (2012)
Yang (2012)84.285.75.794.328.621.0
Balaskas (2011)61.50.050.045.269.031.07.75.5
Hughes (2010)46.210.510.536.847.473.746.160.0
Li (2010)69.222.723.130.827.3100.050.0
Kunkel (2009)71.017.141.79.826.845.829.1
Fonollosa (2009)50.05.694.427.827.875.075.0
Anshu (2008)31.875.910.313.827.63.427.627.60.050.0
Hong (2007)75.07.178.614.328.60.020.0
Parc (2007)10.0100.036.472.780.022.2
Tran (2005)67.010.020.030.035.025.0100.0
Shalaby (1997)83.030.823.138.57.7100.063.6
Li (2011)85.041.758.366.741.783.025.0
Ormerod (2001)90.45.02.017.52.533.347.4
Browning (2000)71.454.212.536.022.2
Villanueva (2000)15.010.033.320.0
Deschenes (1992)71.485.7>0>028.614.366.7
Tamesis (1990)44.429.45.917.647.111.817.68.050.0

ASPPC: acute syphilitic posterior placoid choroiditis; AU: anterior uveitis; CSF: cerebrospinal fluid; HIV: human immunodeficiency virus; IU: intermediate uveitis; PAU: panuveitis; PU: posterior uveitis; VDRL: venereal disease research laboratory test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.